Indeed, a representative panel of human SCLC cell lines (n = 7) derived prior and post-therapy44,45 was almost uniformly resistant to extrinsic apoptosis triggered by TRAIL, which killed a TRAIL-sensitive control non-small cell lung cancer (NSCLC) cell line (Fig. 1f). This evidence concerns the gene TNFSF10 and small cell lung carcinoma.